|
US20030190740A1
(en)
|
1998-10-13 |
2003-10-09 |
The University Of Georgia Research Foundation, Inc |
Stabilized bioactive peptides and methods of identification, synthesis, and use
|
|
KR20020002354A
(ko)
|
1998-10-13 |
2002-01-09 |
추후제출 |
안정화된 생활성 펩티드 및 이들을 동정, 합성 및이용하는 방법
|
|
US7608681B2
(en)
|
1999-12-24 |
2009-10-27 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20040001827A1
(en)
*
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
US20050287153A1
(en)
*
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
DE10012120A1
(de)
*
|
2000-03-13 |
2001-09-27 |
Ktb Tumorforschungs Gmbh |
Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
|
|
ATE368688T1
(de)
|
2000-11-08 |
2007-08-15 |
Fresenius Medical Care Affina |
Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
|
|
EP1377306A1
(en)
|
2001-03-09 |
2004-01-07 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US20030157561A1
(en)
*
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
|
US20050271663A1
(en)
*
|
2001-06-28 |
2005-12-08 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
US6916904B2
(en)
*
|
2002-04-24 |
2005-07-12 |
Zolaris Biosciences, Llc |
Inhibition of immune complex formation
|
|
US20090068178A1
(en)
*
|
2002-05-08 |
2009-03-12 |
Genentech, Inc. |
Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
|
|
WO2003106493A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Dyax Corporation |
Protein analysis
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
EP1600459A3
(en)
*
|
2002-06-28 |
2005-12-07 |
Domantis Limited |
Ligand
|
|
EP2284192A3
(en)
|
2002-11-08 |
2011-07-20 |
Ablynx N.V. |
Camelidae antibodies for sublingual administration
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
US7329725B1
(en)
|
2003-10-29 |
2008-02-12 |
Nastech Pharmaceutical Company Inc. |
Phage displayed Trp cage ligands
|
|
AU2004309347B2
(en)
|
2003-12-19 |
2010-03-04 |
Genentech, Inc. |
Monovalent antibody fragments useful as therapeutics
|
|
US8754031B2
(en)
|
2004-03-08 |
2014-06-17 |
Oncolix, Inc. |
Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
|
|
AU2005221187B2
(en)
*
|
2004-03-10 |
2011-09-01 |
Trinity Therapeutics, Inc. |
Method for inhibiting immune complex formation in a subjetc
|
|
AU2011253771B2
(en)
*
|
2004-03-10 |
2013-10-31 |
Trinity Therapeutics, Inc. |
Method for inhibiting immune complex formation in a subject
|
|
EP1732613A2
(en)
*
|
2004-04-06 |
2006-12-20 |
Affibody AB |
Use of serum albumin binding peptides conjugates for the preparation of a medicament
|
|
MXPA06014065A
(es)
|
2004-06-01 |
2007-01-31 |
Genentech Inc |
Conjugados de droga-anticuerpo y metodos.
|
|
US8921528B2
(en)
*
|
2004-06-01 |
2014-12-30 |
Domantis Limited |
Bispecific fusion antibodies with enhanced serum half-life
|
|
PT1773885E
(pt)
|
2004-08-05 |
2010-07-21 |
Genentech Inc |
Antagonistas anti-cmet humanizados
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
JP4993645B2
(ja)
|
2004-12-01 |
2012-08-08 |
ジェネンテック， インコーポレイテッド |
抗体薬剤結合体および方法
|
|
US20090111745A1
(en)
*
|
2004-12-02 |
2009-04-30 |
Domantis Limited |
Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain Antibodies
|
|
CA2588892A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Dormantis Limited |
Anti-il-1r1 single domain antibodies and therapeutic uses
|
|
BRPI0518761A2
(pt)
*
|
2004-12-02 |
2008-12-09 |
Domantis Ltd |
fusço de droga, conjugado de droga, Ácido nucleico recombinante, construÇço de Ácido nucleico, cÉlula hospedeira, mÉtodo para produzir uma fusço de droga, composiÇço farmacÊutica, droga, mÉtodo de tratamento e/ou prevenÇço de uma condiÇço em um paciente, mÉtodo de retardo ou prevenÇço de progressço de doenÇa, e, mÉtodo para diminuir a absorÇço de alimentos por um paciente
|
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
|
DE102005023617A1
(de)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Verfahren zum Mischen von Farben in einem Display
|
|
JP5329961B2
(ja)
*
|
2005-09-06 |
2013-10-30 |
トリニティー セラピューティクス インコーポレイテッド |
免疫介在性神経疾患を治療するための方法
|
|
EP1940880A2
(en)
*
|
2005-10-14 |
2008-07-09 |
Novo Nordisk A/S |
Treating diabetes using inhibitors of il-1
|
|
KR101434682B1
(ko)
|
2005-12-02 |
2014-08-27 |
제넨테크, 인크. |
결합 폴리펩티드 및 이들의 용도
|
|
US7704953B2
(en)
*
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
|
JP5252435B2
(ja)
|
2006-03-15 |
2013-07-31 |
ノボ・ノルデイスク・エー／エス |
アミリン誘導体
|
|
WO2007140371A2
(en)
|
2006-05-30 |
2007-12-06 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
JP2010505435A
(ja)
*
|
2006-10-11 |
2010-02-25 |
アブリンクス エン．ヴェー． |
本質的にｐＨに非依存的に血清タンパク質に結合するアミノ酸配列、それを含む化合物、およびその使用
|
|
AU2007308792B2
(en)
|
2006-10-27 |
2013-01-24 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
JP2010512734A
(ja)
*
|
2006-12-13 |
2010-04-30 |
アブリンクス エン．ヴェー． |
Ｉｌ−６／ｉｌ−６受容体複合体等受容体介在性シグナル伝達に関与する複合体に特異的なポリペプチド
|
|
CA2673331A1
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
AU2007336243B2
(en)
|
2006-12-19 |
2012-07-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
US9512236B2
(en)
|
2006-12-19 |
2016-12-06 |
Ablynx N.V. |
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
MY183404A
(en)
|
2006-12-19 |
2021-02-18 |
Genentech Inc |
Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
|
|
BRPI0806403A2
(pt)
|
2007-02-09 |
2011-09-06 |
Genentech Inc |
anticorpo anti-robo4, usode um anticorpo e método de obtenção de imagem
|
|
ES2528922T3
(es)
|
2007-07-16 |
2015-02-13 |
Genentech, Inc. |
Anticuerpos anti-CD79b humanizados e inmunoconjugados y métodos de uso
|
|
ATE543835T1
(de)
|
2007-07-16 |
2012-02-15 |
Genentech Inc |
Anti-cd79b-antikörper und immunkonjugate und anwendungsverfahren
|
|
US8937153B2
(en)
|
2007-07-31 |
2015-01-20 |
Affibody Ab |
Compositions, methods and uses
|
|
EP2036923A1
(en)
*
|
2007-09-11 |
2009-03-18 |
Novo Nordisk A/S |
Improved derivates of amylin
|
|
US8629246B2
(en)
|
2007-09-26 |
2014-01-14 |
Ucb Pharma S.A. |
Dual specificity antibody fusions
|
|
KR100920729B1
(ko)
*
|
2007-10-01 |
2009-10-07 |
한국생명공학연구원 |
펩타이드 혼성체를 사용한 배향성이 조절된 항체단분자막의 제조방법
|
|
WO2009068631A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
PT2247620T
(pt)
|
2008-01-31 |
2016-08-23 |
Genentech Inc |
Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
|
|
AU2009235467A1
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Single variable domains against the Notch pathways
|
|
NZ589036A
(en)
|
2008-05-16 |
2012-07-27 |
Ablynx Nv |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
HUE042053T2
(hu)
|
2008-06-05 |
2019-06-28 |
Ablynx Nv |
Vírus burokfehérjéi elleni aminosav-szekvenciák és az azokat tartalmazó polipeptidek virális betegségek kezelésére
|
|
CA2729185A1
(en)
|
2008-06-30 |
2010-01-21 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Methods and compositions for modifying immunobinders
|
|
EP2303230A2
(en)
|
2008-07-10 |
2011-04-06 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Methods and compositions for enhanced delivery of macromolecules
|
|
AU2009270805B2
(en)
|
2008-07-18 |
2016-11-03 |
Trinity Therapeutics, Inc. |
Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
|
|
WO2010035012A1
(en)
|
2008-09-26 |
2010-04-01 |
Ucb Pharma S.A. |
Biological products
|
|
WO2010046357A1
(en)
|
2008-10-21 |
2010-04-29 |
Novo Nordisk A/S |
Amylin derivatives
|
|
KR101593285B1
(ko)
|
2008-10-29 |
2016-02-11 |
아블린쓰 엔.브이. |
단일 도메인 항원 결합 분자의 제형
|
|
CA2739352C
(en)
|
2008-10-29 |
2021-07-13 |
Wyeth Llc |
Methods for purification of single domain antigen binding molecules
|
|
WO2010054699A1
(en)
*
|
2008-11-17 |
2010-05-20 |
Affibody Ab |
Conjugates of albumin binding domain
|
|
PL2752189T3
(pl)
|
2008-11-22 |
2017-04-28 |
F. Hoffmann-La Roche Ag |
Zastosowanie przeciwciała anty-VEGF w połączeniu z chemioterapią do leczenia raka sutka
|
|
AU2009329501B2
(en)
|
2008-12-19 |
2015-11-26 |
Ablynx N.V. |
Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4
|
|
US8648046B2
(en)
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
|
KR101672401B1
(ko)
|
2009-02-26 |
2016-11-16 |
온코릭스, 아이엔씨. |
암 줄기 세포를 가시화하고 제거하기 위한 조성물 및 방법
|
|
HRP20150965T1
(hr)
|
2009-03-25 |
2015-11-06 |
Genentech, Inc. |
Anti-fgr3 protutijela i metode koje ih koriste
|
|
CA2757382A1
(en)
|
2009-04-01 |
2010-10-21 |
Kristi Elkins |
Anti-fcrh5 antibodies and immunoconjugates
|
|
US8748581B2
(en)
|
2009-04-10 |
2014-06-10 |
Ablynx N.V. |
Anti-IL-6R polypeptides and pharmaceutical compositions thereof
|
|
KR101852204B1
(ko)
|
2009-06-05 |
2018-04-26 |
아블린쓰 엔.브이. |
기도 감염의 예방 및/또는 치료를 위한 일가, 이가 및 삼가 항 인간 호흡기 세포융합 바이러스 (ｈｒｓｖ) 나노바디 구조물
|
|
MX336476B
(es)
|
2009-08-15 |
2016-01-20 |
Genentech Inc |
Terapia anti-angiogenesis para el tratamiento de cancer de mama previamente tratado.
|
|
JP2013504585A
(ja)
|
2009-09-09 |
2013-02-07 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
BR112012009412A2
(pt)
|
2009-10-22 |
2016-11-29 |
Genentech Inc |
'anticorpo anti-hepsina isolado, molécula de ácido nucleico, célula hospedeira, método para fabricar um anticorpo, imunoconjugado, formulação farmacêutica, uso do anticorpo e método para fabricar um anticorpo anti-serina protease'
|
|
SI2496601T1
(sl)
|
2009-11-05 |
2017-09-29 |
F. Hoffmann-La Roche Ag |
Tehnike in sestavek za sekrecijo heterolognih polipeptidov
|
|
KR101808751B1
(ko)
|
2009-11-13 |
2017-12-13 |
그리폴스 테라퓨틱스 인코포레이티드 |
폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도
|
|
WO2011064382A1
(en)
|
2009-11-30 |
2011-06-03 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
RU2016105962A
(ru)
|
2009-12-04 |
2018-11-23 |
Дженентек, Инк. |
Мультиспецифические антитела, аналоги антител, композиции и способы
|
|
EP2509997B1
(en)
|
2009-12-07 |
2017-08-30 |
i2 Pharmaceuticals, Inc. |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
|
HRP20251657T1
(hr)
|
2009-12-14 |
2026-02-13 |
Ablynx N.V. |
Imunoglobulinska protutijela s jednostrukom varijabilnom domenom protiv ox40l, konstrukti i njihova terapijska upotreba
|
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
TWI619509B
(zh)
|
2010-02-23 |
2018-04-01 |
建南德克公司 |
治療先前未經治療之ⅲ期或ⅳ期卵巢癌、輸卵管癌或原發性腹膜癌之卡鉑、太平洋紫杉醇與抗-vegf抗體之組合
|
|
EP2552962B1
(en)
|
2010-03-26 |
2016-03-23 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against cxcr7
|
|
WO2011130598A1
(en)
|
2010-04-15 |
2011-10-20 |
Spirogen Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
MX2012013490A
(es)
|
2010-05-20 |
2013-01-29 |
Ablynx Nv |
Materiales biologicos relacionados con her3.
|
|
WO2011153243A2
(en)
|
2010-06-02 |
2011-12-08 |
Genentech, Inc. |
Anti-angiogenesis therapy for treating gastric cancer
|
|
BR112012029866A2
(pt)
|
2010-06-03 |
2017-03-07 |
Genentech Inc |
método para a determinação da presença de uma proteína steap-1
|
|
SG185428A1
(en)
|
2010-06-08 |
2012-12-28 |
Genentech Inc |
Cysteine engineered antibodies and conjugates
|
|
NZ604805A
(en)
|
2010-07-09 |
2014-09-26 |
Affibody Ab |
Polypeptides
|
|
EA201390450A1
(ru)
|
2010-09-28 |
2013-07-30 |
Амилин Фармасьютикалс, Ллк. |
Полипептиды с увеличенной продолжительностью действия
|
|
EP2621953B1
(en)
|
2010-09-30 |
2017-04-05 |
Ablynx N.V. |
Biological materials related to c-met
|
|
EA037063B1
(ru)
|
2010-11-08 |
2021-02-01 |
Аблинкс Н.В. |
Cxcr2-связывающие полипептиды
|
|
WO2012074757A1
(en)
|
2010-11-17 |
2012-06-07 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
CN113278077A
(zh)
|
2010-11-26 |
2021-08-20 |
分子组合公司 |
设计的与血清白蛋白结合的重复蛋白
|
|
CA2827170A1
(en)
|
2011-02-11 |
2012-08-16 |
David M. Hilbert |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
EP2691418A1
(en)
|
2011-03-28 |
2014-02-05 |
Ablynx N.V. |
Bispecific anti-cxcr7 immunoglobulin single variable domains
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
US8679767B2
(en)
|
2011-05-12 |
2014-03-25 |
Genentech, Inc. |
Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides
|
|
KR102072250B1
(ko)
|
2011-05-27 |
2020-03-02 |
아블린쓰 엔.브이. |
Ｒａｎｋｌ 결합 펩티드를 이용한 골 재흡수 억제
|
|
JP2014525736A
(ja)
|
2011-06-23 |
2014-10-02 |
アブリンクス エン．ヴェー． |
ＩｇＥに対する免疫グロブリン単一可変ドメイン
|
|
WO2013003680A1
(en)
|
2011-06-30 |
2013-01-03 |
Genentech, Inc. |
Anti-c-met antibody formulations
|
|
US9382305B2
(en)
|
2011-07-01 |
2016-07-05 |
Bayer Intellectual Property Gmbh |
Relaxin fusion polypeptides and uses thereof
|
|
WO2013007563A1
(en)
|
2011-07-08 |
2013-01-17 |
Bayer Intellectual Property Gmbh |
Fusion proteins releasing relaxin and uses thereof
|
|
US20130022551A1
(en)
|
2011-07-22 |
2013-01-24 |
Trustees Of Boston University |
DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS
|
|
CN103890174B9
(zh)
*
|
2011-08-24 |
2026-04-03 |
大塚化学株式会社 |
IgG结合性肽及利用其检测和纯化IgG的方法
|
|
EP2758422A1
(en)
|
2011-09-23 |
2014-07-30 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, SA |
Modified albumin-binding domains and uses thereof to improve pharmacokinetics
|
|
BR112014006929A2
(pt)
|
2011-09-23 |
2017-04-04 |
Technophage Investigação E Desenvolvimento Em Biotecnologia Sa |
agentes anti-fator de necrose tumoral-alfa e seus usos
|
|
EP2747782B1
(en)
|
2011-09-23 |
2018-01-17 |
Ablynx NV |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
CN103889451B
(zh)
|
2011-09-30 |
2016-06-29 |
埃博灵克斯股份有限公司 |
与C-Met相关的生物物质
|
|
PT2750713E
(pt)
|
2011-10-14 |
2016-01-20 |
Genentech Inc |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
US9803004B2
(en)
|
2011-11-11 |
2017-10-31 |
Ucb Biopharma Sprl |
Albumin binding antibodies and binding fragments thereof
|
|
ES2680151T3
(es)
*
|
2012-03-01 |
2018-09-04 |
Amgen Research (Munich) Gmbh |
Moléculas de unión de polipéptidos de larga duración
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
US20160009767A9
(en)
|
2012-03-28 |
2016-01-14 |
Affibody Ab |
Oral administration
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
KR20220051197A
(ko)
|
2012-05-17 |
2022-04-26 |
익스텐드 바이오사이언시즈, 인크. |
개선된 약물 전달용 캐리어
|
|
US8822423B2
(en)
*
|
2012-05-17 |
2014-09-02 |
Janssen Biotech, Inc. |
Affinity peptides toward infliximab
|
|
BR112014029409B1
(pt)
|
2012-05-25 |
2022-11-29 |
Janssen Biotech, Inc |
Domínio de ligação a albumina isolado não natural, método para produção do mesmo, polinucleotídeo isolado, vetor isolado, célula hospedeira isolada, proteína de fusão e composição farmacêutica
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
US9856314B2
(en)
|
2012-06-22 |
2018-01-02 |
Cytomx Therapeutics, Inc. |
Activatable antibodies having non-binding steric moieties and methods of using the same
|
|
WO2014003176A1
(ja)
*
|
2012-06-29 |
2014-01-03 |
旭化成メディカル株式会社 |
プロテインａのｂドメイン変異体を含むポリペプチドが結合された担体からなる吸着材
|
|
US10155792B2
(en)
|
2012-09-25 |
2018-12-18 |
Affibody Ab |
Albumin binding polypeptide
|
|
NZ707486A
(en)
|
2012-10-12 |
2018-09-28 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine - anti-psma antibody conjugates
|
|
US9931414B2
(en)
|
2012-10-12 |
2018-04-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
BR112015008251B1
(pt)
|
2012-10-12 |
2023-09-26 |
Medimmune Limited |
Pirrolobenzodiazepinas, conjugados destas, composição e composição farmacêutica compreendendo os conjugados, uso dos conjugados para o tratamento de uma doença proliferativa e método para preparar os conjugados
|
|
WO2014057114A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
EP2906296B1
(en)
|
2012-10-12 |
2018-03-21 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
ES2649990T3
(es)
|
2012-10-12 |
2018-01-16 |
Medimmune Limited |
Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas
|
|
ES2738310T3
(es)
|
2012-10-12 |
2020-01-21 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
EP2912051B1
(en)
|
2012-10-25 |
2018-04-18 |
Affibody AB |
Method for the separation of proteins containing an albumin-binding domain
|
|
AU2013336646B2
(en)
|
2012-10-25 |
2016-07-14 |
Affibody Ab |
ABD binding polypeptide
|
|
HK1216176A1
(zh)
|
2012-12-21 |
2016-10-21 |
Medlmmune Limited |
用於治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
|
|
BR112015014669B1
(pt)
|
2012-12-21 |
2023-09-26 |
Medimmune Limited |
Compostos pirrolobenzodiazepinas, conjugados compreendendo os mesmos e uso destes para tratar uma doença proliferativa
|
|
EP2752426A1
(en)
|
2013-01-03 |
2014-07-09 |
Covagen AG |
Human serum albumin binding compounds and fusion proteins thereof
|
|
US9605029B2
(en)
|
2013-01-28 |
2017-03-28 |
National Institute Of Advanced Industrial Science And Technology |
Antibody-binding peptide
|
|
CA2905181C
(en)
|
2013-03-13 |
2020-06-02 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
|
|
AU2014244245C1
(en)
|
2013-03-13 |
2018-04-19 |
Genentech, Inc. |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN105142674B
(zh)
|
2013-03-13 |
2018-11-13 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
EP2968587A2
(en)
|
2013-03-13 |
2016-01-20 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
|
EP2970449B1
(en)
|
2013-03-15 |
2019-09-25 |
Amgen Research (Munich) GmbH |
Single chain binding molecules comprising n-terminal abp
|
|
JP6993084B2
(ja)
|
2013-08-12 |
2022-02-03 |
ジェネンテック， インコーポレイテッド |
１－（クロロメチル）－２，３－ジヒドロ－１ｈ－ベンゾ［ｅ］インドール二量体抗体 － 薬物コンジュゲート化合物、並びに使用及び処置の方法
|
|
EP3054986B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3054983B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CA2928952A1
(en)
|
2013-12-16 |
2015-06-25 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
EP3082876B1
(en)
|
2013-12-16 |
2018-01-17 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
UA118113C2
(uk)
|
2013-12-16 |
2018-11-26 |
Дженентек, Інк. |
Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом
|
|
EP3083675B1
(en)
|
2013-12-20 |
2018-03-07 |
Affibody AB |
Engineered albumin binding polypeptide
|
|
WO2015132248A2
(en)
*
|
2014-03-03 |
2015-09-11 |
Vrije Universiteit Brussel (Vub) |
Sequamers - a novel non-natural type of peptide libraries randomly constrained by their primary sequences
|
|
PL3116999T3
(pl)
|
2014-03-14 |
2021-12-27 |
F.Hoffmann-La Roche Ag |
Sposoby i kompozycje do wydzielania polipeptydów heterologicznych
|
|
MX2016012285A
(es)
|
2014-03-24 |
2017-01-23 |
Genentech Inc |
Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf.
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
SG10201913507SA
(en)
*
|
2014-05-02 |
2020-02-27 |
Momenta Pharmaceuticals Inc |
Compositions and methods related to engineered fc constructs
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
TW201625688A
(zh)
|
2014-09-12 |
2016-07-16 |
建南德克公司 |
經半胱胺酸改造之抗體及接合物
|
|
US10149913B2
(en)
|
2014-09-12 |
2018-12-11 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
JP2017533887A
(ja)
|
2014-09-17 |
2017-11-16 |
ジェネンテック， インコーポレイテッド |
ピロロベンゾジアゼピン類及びその抗体ジスルフィドコンジュゲート
|
|
DK3262071T3
(da)
|
2014-09-23 |
2020-06-15 |
Hoffmann La Roche |
Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater
|
|
US9585934B2
(en)
|
2014-10-22 |
2017-03-07 |
Extend Biosciences, Inc. |
Therapeutic vitamin D conjugates
|
|
WO2016065052A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Insulin vitamin d conjugates
|
|
US9789197B2
(en)
|
2014-10-22 |
2017-10-17 |
Extend Biosciences, Inc. |
RNAi vitamin D conjugates
|
|
CN107108740B
(zh)
|
2014-11-05 |
2021-09-17 |
豪夫迈·罗氏有限公司 |
抗fgfr2/3抗体及其使用方法
|
|
EP3223854A1
(en)
|
2014-11-25 |
2017-10-04 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MX2017007169A
(es)
|
2014-12-03 |
2018-05-02 |
Genentech Inc |
Compuestos de amina cuaternaria y conjugados de anticuerpofármaco de los mismos.
|
|
CN107109381A
(zh)
|
2014-12-19 |
2017-08-29 |
阿雷克森制药公司 |
治疗组织钙化的方法
|
|
CA2981398A1
(en)
|
2015-04-02 |
2016-10-06 |
Ablynx N.V. |
Bispecific cxcr4-cd4 polypeptides with potent anti-hiv activity
|
|
WO2016161388A1
(en)
|
2015-04-03 |
2016-10-06 |
University Of Massachusetts |
Fully stabilized asymmetric sirna
|
|
WO2016164308A1
(en)
|
2015-04-06 |
2016-10-13 |
Subdomain, Llc |
De novo binding domain containing polypeptides and uses thereof
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
US11046767B2
(en)
|
2015-05-13 |
2021-06-29 |
Ablynx N.V. |
T cell recruiting polypeptides based on CD3 reactivity
|
|
PT3294768T
(pt)
|
2015-05-13 |
2019-11-05 |
Ablynx Nv |
Polipétidos de recrutamento de células t com base na reatividade do tcr alfa/beta
|
|
CN107743494B
(zh)
|
2015-06-02 |
2022-04-29 |
诺和诺德股份有限公司 |
具有极性重组延伸体的胰岛素
|
|
WO2017030973A1
(en)
|
2015-08-14 |
2017-02-23 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
|
EP3355931B1
(en)
|
2015-10-01 |
2024-06-26 |
Novo Nordisk A/S |
Protein conjugates
|
|
SG11201803001WA
(en)
|
2015-10-23 |
2018-05-30 |
Fujifilm Corp |
Cyclic peptide, affinity chromatography support, labeled antibody, antibody drug conjugate, and pharmaceutical preparation
|
|
CN108473561B
(zh)
|
2015-11-27 |
2022-12-16 |
埃博灵克斯股份有限公司 |
抑制cd40l的多肽
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
US10478503B2
(en)
|
2016-01-31 |
2019-11-19 |
University Of Massachusetts |
Branched oligonucleotides
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
US10821160B2
(en)
|
2016-03-01 |
2020-11-03 |
The Board Of Trustees Of The University Of Illinois |
L-asparaginase variants and fusion proteins with reduced L-glutaminase activity and enhanced stability
|
|
WO2017151971A2
(en)
|
2016-03-02 |
2017-09-08 |
Momenta Pharmaceuticals, Inc. |
METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
|
|
US20170315132A1
(en)
|
2016-03-25 |
2017-11-02 |
Genentech, Inc. |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
|
CN109642869B
(zh)
|
2016-04-15 |
2022-04-12 |
伯克利之光生命科技公司 |
用于坞内测定的方法、系统和试剂盒
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
CA3025310A1
(en)
|
2016-05-23 |
2017-11-30 |
Momenta Pharmaceuticals, Inc. |
Compositions and methods related to engineered fc constructs
|
|
JP7022080B2
(ja)
|
2016-05-27 |
2022-02-17 |
ジェネンテック， インコーポレイテッド |
部位特異的抗体－薬物複合体の特徴付けのための生化学分析的方法
|
|
WO2017210425A1
(en)
*
|
2016-06-03 |
2017-12-07 |
Janssen Biotech, Inc. |
Serum albumin-binding fibronectin type iii domains
|
|
EP3471747A1
(en)
|
2016-06-16 |
2019-04-24 |
Alexion Pharmaceuticals, Inc. |
Methods of treating myointimal proliferation
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
US11753638B2
(en)
|
2016-08-12 |
2023-09-12 |
University Of Massachusetts |
Conjugated oligonucleotides
|
|
WO2018043629A1
(ja)
|
2016-09-01 |
2018-03-08 |
国立研究開発法人産業技術総合研究所 |
非天然型立体構造を形成した抗体に親和性を示すポリペプチド
|
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
CN109790202B
(zh)
*
|
2016-09-30 |
2022-09-13 |
富士胶片株式会社 |
环肽、亲和层析载体、标记抗体、抗体药物复合体及药物制剂
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US11912750B2
(en)
|
2016-11-10 |
2024-02-27 |
Keros Therapeutics, Inc. |
GDNF fusion polypeptides and methods of use thereof
|
|
IL317416A
(en)
|
2016-11-16 |
2025-02-01 |
Ablynx Nv |
T cell-recruiting polypeptides capable of binding CD123 and TCR alpha/beta
|
|
KR102624254B1
(ko)
|
2017-01-06 |
2024-01-12 |
모멘타 파머슈티컬스 인코포레이티드 |
유전자 조작 Fc 작제물에 관한 조성물 및 방법
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MA49339A
(fr)
|
2017-04-05 |
2020-02-12 |
Novo Nordisk As |
Conjugués insuline-fc à extension oligomère
|
|
EP3612537B1
(en)
|
2017-04-18 |
2022-07-13 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
CN110536703B
(zh)
|
2017-04-20 |
2024-07-12 |
Adc治疗有限公司 |
使用抗axl抗体-药物缀合物的组合疗法
|
|
ES3066090T3
(en)
|
2017-04-28 |
2026-05-11 |
Ajinomoto Co Inc |
Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof
|
|
MX2019014397A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Polipeptidos que enlazan adamts5, mmp13 y agrecano.
|
|
CN111032695B
(zh)
|
2017-06-02 |
2024-06-25 |
默克专利股份有限公司 |
结合adamts的免疫球蛋白
|
|
MX2019014504A
(es)
|
2017-06-02 |
2020-07-20 |
Merck Patent Gmbh |
Inmunoglobulinas de union a agrecano.
|
|
CN110997001A
(zh)
|
2017-06-02 |
2020-04-10 |
默克专利股份有限公司 |
Mmp13结合免疫球蛋白
|
|
UA127900C2
(uk)
|
2017-06-14 |
2024-02-07 |
Ейдісі Терапьютікс Са |
Схема дозування для введення adc до cd19
|
|
CA3064590A1
(en)
|
2017-06-23 |
2018-12-27 |
University Of Massachusetts |
Two-tailed self-delivering sirna and related methods
|
|
CN111201246B
(zh)
|
2017-07-11 |
2023-10-27 |
亚力兄制药公司 |
结合补体成分c5或血清白蛋白的多肽及其融合蛋白
|
|
US11077199B2
(en)
*
|
2017-08-09 |
2021-08-03 |
Massachusetts Institute Of Technology |
Albumin binding peptide conjugates and methods thereof
|
|
AU2018313253B2
(en)
|
2017-08-11 |
2024-09-26 |
The Board Of Trustees Of The University Of Illinois |
Truncated guinea pig L-asparaginase variants and methods of use
|
|
RS62928B1
(sr)
|
2017-08-18 |
2022-03-31 |
Medimmune Ltd |
Konjugati pirolobenzodiazepina
|
|
JP7511469B2
(ja)
|
2017-09-27 |
2024-07-05 |
イノザイム ファーマ， インコーポレイテッド |
組換えエクトヌクレオチドピロホスファターゼ／ホスホジエステラーゼ（ｎｐｐ１）を使用して心血管機能を改善し、心血管疾患を処置するための方法。
|
|
SG11202002982YA
(en)
|
2017-10-10 |
2020-04-29 |
Numab Therapeutics AG |
Multispecific antibody
|
|
WO2019075476A2
(en)
|
2017-10-15 |
2019-04-18 |
Berkeley Lights, Inc. |
METHODS, SYSTEMS AND KITS FOR ENCLOSED TESTS
|
|
WO2019099440A1
(en)
|
2017-11-14 |
2019-05-23 |
Arcellx, Inc. |
Multifunctional immune cell therapies
|
|
BR112020009136A2
(pt)
|
2017-11-14 |
2020-10-13 |
Arcellx, Inc. |
polipeptídeos que contêm domínio d e usos dos mesmos
|
|
KR102037336B1
(ko)
*
|
2017-11-29 |
2019-10-29 |
아주대학교산학협력단 |
항체와 생리활성물질의 접합방법
|
|
WO2019107962A2
(ko)
*
|
2017-11-29 |
2019-06-06 |
아주대학교 산학협력단 |
항체와 생리활성물질의 접합방법
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JPWO2019240288A1
(ja)
|
2018-06-14 |
2021-07-26 |
味の素株式会社 |
抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩
|
|
EP3807321A4
(en)
|
2018-06-18 |
2022-03-02 |
Anwita Biosciences, Inc. |
ANTI-MESOTHELIN CONSTRUCTS AND USES THEREOF
|
|
WO2020033899A1
(en)
|
2018-08-10 |
2020-02-13 |
University Of Massachusetts |
Modified oligonucleotides targeting snps
|
|
JP7627042B2
(ja)
|
2018-08-23 |
2025-02-05 |
ユニバーシティー オブ マサチューセッツ |
Ｏ－メチルリッチ完全安定化オリゴヌクレオチド
|
|
MX2021003543A
(es)
|
2018-09-27 |
2021-06-23 |
Xilio Dev Inc |
Polipeptidos de citocinas enmascaradas.
|
|
WO2020090979A1
(ja)
|
2018-10-31 |
2020-05-07 |
味の素株式会社 |
抗体に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩
|
|
EP3894427A1
(en)
|
2018-12-10 |
2021-10-20 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
BR112021009750A2
(pt)
|
2018-12-20 |
2021-08-17 |
Kleo Pharmaceuticals, Inc |
terapia de combinação de arms e células exterminadoras naturais
|
|
WO2020150636A1
(en)
*
|
2019-01-18 |
2020-07-23 |
University Of Massachusetts |
Dynamic pharmacokinetic-modifying anchors
|
|
ES2967878T3
(es)
|
2019-03-15 |
2024-05-06 |
Medimmune Ltd |
Dímeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento del cáncer
|
|
CA3149835A1
(en)
|
2019-08-09 |
2021-02-18 |
University Of Massachusetts |
Chemically modified oligonucleotides targeting snps
|
|
US12365894B2
(en)
|
2019-09-16 |
2025-07-22 |
University Of Massachusetts |
Branched lipid conjugates of siRNA for specific tissue delivery
|
|
EP3816185A1
(en)
|
2019-11-04 |
2021-05-05 |
Numab Therapeutics AG |
Multispecific antibody directed against pd-l1 and a tumor-associated antigen
|
|
CA3161723A1
(en)
|
2019-12-18 |
2021-06-24 |
Karyn O'neil |
Serum albumin-binding fibronectin type iii domains and uses thereof
|
|
GB201919061D0
(en)
|
2019-12-20 |
2020-02-05 |
Ucb Biopharma Sprl |
Multi-specific antibody
|
|
WO2021183458A2
(en)
|
2020-03-09 |
2021-09-16 |
Berkeley Lights, Inc. |
Methods, systems and kits for in-pen assays
|
|
EP4157289A4
(en)
|
2020-05-26 |
2024-06-26 |
University Of Massachusetts |
Synthetic oligonucleotides having regions of block and cluster modifications
|
|
EP3915580A1
(en)
|
2020-05-29 |
2021-12-01 |
Numab Therapeutics AG |
Multispecific antibody
|
|
JP7748944B2
(ja)
|
2020-06-30 |
2025-10-03 |
株式会社ガイアバイオメディシン |
Ｎｋ細胞と抗体との結合を安定化する方法、及びその利用
|
|
EP3988568A1
(en)
|
2020-10-21 |
2022-04-27 |
Numab Therapeutics AG |
Combination treatment
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
KR20230117588A
(ko)
|
2020-12-07 |
2023-08-08 |
유씨비 바이오파마 에스알엘 |
다중특이적 항체 및 항체 조합
|
|
US20240392003A1
(en)
|
2021-02-02 |
2024-11-28 |
Numab Therapeutics AG |
Multispecific antibodies having specificity for ror1 and cd3
|
|
CN117321076A
(zh)
|
2021-02-19 |
2023-12-29 |
美国卫生及公众服务部代表 |
中和SARS-CoV-2的单结构域抗体
|
|
CN117425484A
(zh)
|
2021-03-26 |
2024-01-19 |
阿奇利克斯股份有限公司 |
多功能免疫细胞疗法
|
|
AR126207A1
(es)
|
2021-06-23 |
2023-09-27 |
Univ Massachusetts |
Compuestos de oligonucleotidos anti-flt1 optimizados para el tratamiento de la preeclampsia y otros desordenes angiogénicos
|
|
EP4183800A1
(en)
|
2021-11-19 |
2023-05-24 |
Medizinische Hochschule Hannover |
Novel sars-cov-2 neutralizing antibodies
|
|
WO2023167564A1
(ko)
|
2022-03-04 |
2023-09-07 |
앱티스 주식회사 |
티올 반응성 에디티브를 이용한 항체-약물 컨쥬게이트의 제조 수율을 높이는 방법
|
|
KR20250019100A
(ko)
|
2022-06-02 |
2025-02-07 |
아지노모토 가부시키가이샤 |
친화성 물질, 화합물, 항체 및 그것들의 염
|
|
PE20251082A1
(es)
|
2022-07-08 |
2025-04-10 |
Novo Nordisk As |
Compuestos de isvd altamente potentes capaces de sustituir al fviii(a)
|
|
WO2024038095A1
(en)
|
2022-08-16 |
2024-02-22 |
Iome Bio |
NOVEL ANTI-RGMb ANTIBODIES
|
|
EP4593867A2
(en)
|
2022-09-30 |
2025-08-06 |
Extend Biosciences, Inc. |
Long-acting parathyroid hormone
|
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
WO2024243238A1
(en)
*
|
2023-05-22 |
2024-11-28 |
Kaida Biopharmaceuticals, Inc. |
Antagonist fusion polypeptides
|
|
US12473529B2
(en)
|
2023-07-18 |
2025-11-18 |
Nanotein Technologies, Inc. |
Reagents, reagent kits, and culture media for activating and expanding immune cells and uses thereof
|
|
US12377158B1
(en)
*
|
2024-07-05 |
2025-08-05 |
Michael Farber |
Enhanced peptide constructs for albumin binding
|
|
JP7826558B1
(ja)
|
2024-10-11 |
2026-03-09 |
ノヴォ ノルディスク アー／エス |
ヒトｆｇｆ２３のアンタゴニスト
|